|
|
Other links at Articles > Dermatology |
| 5. |
U.S. Regulator Agrees to Study Botox Rival
|
|
|
French drugs group Ipsen and its U.S. partner Medicis said on Monday the Food and Drug Administration had agreed to evaluate Reloxin for cosmetic use in a potential boost for the would-be Botox competitor. Reuters Health Information
|
|
|